miRNA-based strategy for modulation of influenza A virus infection.

Influenza A virus is known worldwide as a threat associated with human and livestock diseases. Hence, identification of physiological and molecular aspects of influenza A could contribute to better design of therapeutic approaches for reducing adverse effects associated with disease caused by this virus. miRNAs are epigenetic regulators playing important roles in many pathological processes that help in progression of influenza A. Besides miRNAs, exosomes have ememrged as other effective players in influenza A pathogenesis. Exosomes exert their effects via targeting their cargos (e.g., DNAs, mRNA, miRNAs and proteins) to recipient cells. Here, we summarized various roles of miRNAs and exosomes in influenza A pathogenesis. Moreover, we highlighted therapeutic applications of miRNAs and exosomes in influenza.

[1]  M. Nourbakhsh,et al.  Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin , 2019, BMC Cancer.

[2]  Yang Yang,et al.  MicroRNA Expression Profile in Peripheral Blood Lymphocytes of Sheep Vaccinated with Nigeria 75/1 Peste Des Petits Ruminants Virus , 2019, Viruses.

[3]  P. Mehrbod,et al.  Association of polymorphisms in inflammatory cytokines encoding genes with severe cases of influenza A/H1N1 and B in an Iranian population , 2019, Virology Journal.

[4]  Mariana Marques,et al.  Cellular Proteostasis During Influenza A Virus Infection—Friend or Foe? , 2019, Cells.

[5]  H. Mirzaei,et al.  MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers , 2018, Journal of cellular physiology.

[6]  H. Mirzaei,et al.  Circulating miR-21 as novel biomarker in gastric cancer: Diagnostic and prognostic biomarker , 2018, Journal of cancer research and therapeutics.

[7]  Mohammad Mashreghi,et al.  Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis , 2018, Journal of cellular physiology.

[8]  H. Mirzaei,et al.  NLRP3 inflammasome: Its regulation and involvement in atherosclerosis , 2018, Journal of cellular physiology.

[9]  S. Kouhpayeh,et al.  MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy , 2018, Journal of cellular physiology.

[10]  Hamed Mirzaei,et al.  MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer , 2018, Journal of cellular physiology.

[11]  A. Avan,et al.  GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma , 2018, Journal of cellular physiology.

[12]  P. Codoñer-Franch,et al.  Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome , 2018, Journal of cellular biochemistry.

[13]  H. Mirzaei,et al.  MiR‐21: A key player in glioblastoma pathogenesis , 2018, Journal of cellular biochemistry.

[14]  J. Stenvang,et al.  State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia , 2018, Journal of cellular physiology.

[15]  M. Boshtam,et al.  Plasminogen Activator Inhibitor Type‐1 as a Regulator of Fibrosis , 2018, Journal of cellular biochemistry.

[16]  Mohsen Poursadeghiyan,et al.  Diet and cancer prevention: Dietary compounds, dietary MicroRNAs, and dietary exosomes , 2018, Journal of cellular biochemistry.

[17]  H. Mirzaei Stroke in Women: Risk Factors and Clinical Biomarkers , 2017, Journal of cellular biochemistry.

[18]  Mohammad Goodarzi,et al.  Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale? , 2017, Journal of cellular physiology.

[19]  T. Ochiya,et al.  Extracellular Vesicles: New Players in Lung Immunity , 2017, American journal of respiratory cell and molecular biology.

[20]  H. Mirzaei,et al.  Anti‐Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis , 2017, Journal of cellular physiology.

[21]  Ying Zhu,et al.  MicroRNA-302a suppresses influenza A virus–stimulated interferon regulatory factor-5 expression and cytokine storm induction , 2017, The Journal of Biological Chemistry.

[22]  Qiaojun He,et al.  Macrophage Polarization: Anti‐Cancer Strategies to Target Tumor‐Associated Macrophage in Breast Cancer , 2017, Journal of cellular biochemistry.

[23]  C. Culbertson,et al.  Effects of storage temperature on airway exosome integrity for diagnostic and functional analyses , 2017, Journal of extracellular vesicles.

[24]  Wenlin Huang,et al.  Influenza A virus-induced downregulation of miR-26a contributes to reduced IFNα/β production , 2017, Virologica Sinica.

[25]  Bahman Rashidi,et al.  MicroRNA: A novel target of curcumin in cancer therapy , 2017, Journal of cellular physiology.

[26]  Jiansheng Lu,et al.  The highly pathogenic H5N1 influenza A virus down‐regulated several cellular MicroRNAs which target viral genome , 2017, Journal of cellular and molecular medicine.

[27]  S. Kong,et al.  Identification of serum MicroRNAs as diagnostic biomarkers for influenza H7N9 infection , 2017 .

[28]  H. Mirzaei,et al.  Green tea and its anti-angiogenesis effects. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[29]  D. Beezhold,et al.  Upregulation of miRNA-4776 in Influenza Virus Infected Bronchial Epithelial Cells Is Associated with Downregulation of NFKBIB and Increased Viral Survival , 2017, Viruses.

[30]  D. Wang,et al.  MicroRNA‐146a induction during influenza H3N2 virus infection targets and regulates TRAF6 levels in human nasal epithelial cells (hNECs) , 2017, Experimental cell research.

[31]  A. Puustinen,et al.  Proteomic and Bioinformatic Characterization of Extracellular Vesicles Released from Human Macrophages upon Influenza A Virus Infection. , 2017, Journal of proteome research.

[32]  Maolin Zhang,et al.  Modulation of influenza A virus replication by microRNA‐9 through targeting MCPIP1 , 2017, Journal of medical virology.

[33]  S. Mousavi,et al.  Glioblastoma: exosome and microRNA as novel diagnosis biomarkers , 2016, Cancer Gene Therapy.

[34]  Gregory J. Goodall,et al.  A network-biology perspective of microRNA function and dysfunction in cancer , 2016, Nature Reviews Genetics.

[35]  A. Avan,et al.  Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives. , 2016, Current medicinal chemistry.

[36]  R. Salehi,et al.  Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies. , 2016, Current cancer drug targets.

[37]  M. Jaafari,et al.  Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma , 2016, Cancer Gene Therapy.

[38]  Jiantao Wang,et al.  MicroRNA 34a contributes to virus-mediated apoptosis through binding to its target gene Bax in influenza A virus infection. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[39]  A. Sahebkar,et al.  Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia , 2016, Cancer Gene Therapy.

[40]  Mohammad Jafari,et al.  Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers. , 2016, Current pharmaceutical design.

[41]  B. Nakstad,et al.  The role of microRNAs in respiratory viral infection: friend or foe? , 2016, Reviews in medical virology.

[42]  Weilin Wu,et al.  MicroRNA Regulation of Human Genes Essential for Influenza A (H7N9) Replication , 2016, PloS one.

[43]  A. Tuttolomondo,et al.  A Case Report of IgG4-related Syndrome and Literature Review. , 2016, Current pharmaceutical design.

[44]  G. Cheng,et al.  Influenza Virus Affects Intestinal Microbiota and Secondary Salmonella Infection in the Gut through Type I Interferons , 2016, PLoS pathogens.

[45]  M. Samir,et al.  Small Non-coding RNAs Associated with Viral Infectious Diseases of Veterinary Importance: Potential Clinical Applications , 2016, Front. Vet. Sci..

[46]  Dongming Zhou,et al.  Hemagglutinin-targeting Artificial MicroRNAs Expressed by Adenovirus Protect Mice From Different Clades of H5N1 Infection , 2016, Molecular Therapy - Nucleic Acids.

[47]  Hamed Mirzaei,et al.  SiRNA and epigenetic aberrations in ovarian cancer. , 2016, Journal of cancer research and therapeutics.

[48]  Paul S. Foster,et al.  Targeting MicroRNA Function in Respiratory Diseases: Mini-Review , 2016, Front. Physiol..

[49]  Y. Guan,et al.  Interventions to reduce zoonotic and pandemic risks from avian influenza in Asia. , 2016, The Lancet. Infectious diseases.

[50]  J. Makkoch,et al.  Human microRNAs profiling in response to influenza A viruses (subtypes pH1N1, H3N2, and H5N1) , 2016, Experimental biology and medicine.

[51]  S. Kong,et al.  Identification of microRNAs in Throat Swab as the Biomarkers for Diagnosis of Influenza , 2016, International journal of medical sciences.

[52]  Ying Zhu,et al.  Mir‐302c mediates influenza A virus‐induced IFNβ expression by targeting NF‐κB inducing kinase , 2015, FEBS letters.

[53]  A. Kuno,et al.  Influenza A Virus-Induced Expression of a GalNAc Transferase, GALNT3, via MicroRNAs Is Required for Enhanced Viral Replication , 2015, Journal of Virology.

[54]  P. Sharp,et al.  Elucidating MicroRNA Regulatory Networks Using Transcriptional, Post-transcriptional, and Histone Modification Measurements. , 2015, Cell reports.

[55]  J. Ragoussis,et al.  Pattern recognition receptor mediated downregulation of microRNA‐650 fine‐tunes MxA expression in dendritic cells infected with influenza A virus , 2015, European journal of immunology.

[56]  W. Xie,et al.  Proinflammatory effects of the hemagglutinin protein of the avian influenza A (H7N9) virus and microRNA‑mediated homeostasis response in THP‑1 cells. , 2015, Molecular medicine reports.

[57]  L. Orozco,et al.  Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection. , 2015, Experimental and molecular pathology.

[58]  J. Del Favero,et al.  miRVaS: a tool to predict the impact of genetic variants on miRNAs , 2015, Nucleic acids research.

[59]  Yu Zhang,et al.  siRNA Versus miRNA as Therapeutics for Gene Silencing , 2015, Molecular therapy. Nucleic acids.

[60]  Zheng Xing,et al.  Attenuation of the influenza virus by microRNA response element in vivo and protective efficacy against 2009 pandemic H1N1 virus in mice. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[61]  M. Alenquer,et al.  Exosome Biogenesis, Regulation, and Function in Viral Infection , 2015, Viruses.

[62]  J. Makkoch,et al.  Human miR-3145 inhibits influenza A viruses replication by targeting and silencing viral PB1 gene , 2015, Experimental biology and medicine.

[63]  H. Ho,et al.  A non-PCR SPR platform using RNase H to detect MicroRNA 29a-3p from throat swabs of human subjects with influenza A virus H1N1 infection. , 2015, The Analyst.

[64]  X. Bao,et al.  Exosomes and Their Role in the Life Cycle and Pathogenesis of RNA Viruses , 2015, Viruses.

[65]  L. Coughlan,et al.  Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges , 2015, Vaccines.

[66]  Jessica K. Fiege,et al.  Investigating Influenza A Virus Infection: Tools To Track Infection and Limit Tropism , 2015, Journal of Virology.

[67]  Jonathan van Eyll,et al.  Pathway analysis from lists of microRNAs: common pitfalls and alternative strategy , 2015, Nucleic acids research.

[68]  Sam Griffiths-Jones,et al.  Bias in microRNA functional enrichment analysis , 2015, Bioinform..

[69]  R. Prasad,et al.  Gene silencing: a therapeutic approach to combat influenza virus infections. , 2015, Future microbiology.

[70]  K. Zen,et al.  Honeysuckle-encoded atypical microRNA2911 directly targets influenza A viruses , 2014, Cell Research.

[71]  G. Szabo,et al.  Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[72]  S. Ye,et al.  miRNA modulation of SOCS1 using an influenza A virus delivery system. , 2014, The Journal of general virology.

[73]  E. Fodor,et al.  Conserved and host-specific features of influenza virion architecture , 2014, Nature Communications.

[74]  Maolin Zhang,et al.  Induction of the cellular miR-29c by influenza virus inhibits the innate immune response through protection of A20 mRNA. , 2014, Biochemical and biophysical research communications.

[75]  Ke Xu,et al.  Comprehensive Characterization of Serum MicroRNA Profile in Response to the Emerging Avian Influenza A (H7N9) Virus Infection in Humans , 2014, Viruses.

[76]  Lesley Cheng,et al.  Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood , 2014, Journal of extracellular vesicles.

[77]  D. Beezhold,et al.  Expression of non-structural-1A binding protein in lung epithelial cells is modulated by miRNA-548an on exposure to influenza A virus. , 2013, Virology.

[78]  Xin Li,et al.  A computational method for predicting regulation of human microRNAs on the influenza virus genome , 2013, BMC Systems Biology.

[79]  Sugunavathi Sepramaniam,et al.  microRNAs in Circulation Are Altered in Response to Influenza A Virus Infection in Humans , 2013, PloS one.

[80]  C. Horvath,et al.  Small RNA Profiling of Influenza A Virus-Infected Cells Identifies miR-449b as a Regulator of Histone Deacetylase 1 and Interferon Beta , 2013, PloS one.

[81]  R. Albrecht,et al.  MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies , 2013, Nature Biotechnology.

[82]  R. Tripp,et al.  Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs , 2013, PloS one.

[83]  Jun Cheng,et al.  Microarray analysis of MicroRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1) , 2013, BMC Infectious Diseases.

[84]  S. Tsui,et al.  Effect of avian influenza A H5N1 infection on the expression of microRNA-141 in human respiratory epithelial cells , 2013, BMC Microbiology.

[85]  J. Bourdon,et al.  Host microRNA molecular signatures associated with human H1N1 and H3N2 influenza A viruses reveal an unanticipated antiviral activity for miR-146a. , 2013, The Journal of general virology.

[86]  N. Tony Eissa The exosome in lung diseases: Message in a bottle. , 2013, The Journal of allergy and clinical immunology.

[87]  B. Cullen MicroRNAs as mediators of viral evasion of the immune system , 2013, Nature Immunology.

[88]  S. Lakhani,et al.  MicroRNA-182-5p targets a network of genes involved in DNA repair. , 2013, RNA.

[89]  Garnet Navarro,et al.  miR-451 Regulates Dendritic Cell Cytokine Responses to Influenza Infection , 2012, The Journal of Immunology.

[90]  D. Wichadakul,et al.  A computational tool for the design of live attenuated virus vaccine based on microRNA-mediated gene silencing , 2012, BMC Genomics.

[91]  Xin Li,et al.  Human encoded miRNAs that regulate the inflenenza virus genome , 2012, 2012 IEEE 6th International Conference on Systems Biology (ISB).

[92]  X. Bo,et al.  Cellular microRNA let-7c inhibits M1 protein expression of the H1N1 influenza A virus in infected human lung epithelial cells , 2012, Journal of cellular and molecular medicine.

[93]  S. Barik New treatments for influenza , 2012, BMC Medicine.

[94]  Maolin Zhang,et al.  Induction of the cellular microRNA-29c by influenza virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors BCL2L2. , 2012, Biochemical and biophysical research communications.

[95]  Karen E. Johnson,et al.  Influenza A Virus Infection of Human Respiratory Cells Induces Primary MicroRNA Expression* , 2012, The Journal of Biological Chemistry.

[96]  Sandra Diederich,et al.  Temporal- and Strain-Specific Host MicroRNA Molecular Signatures Associated with Swine-Origin H1N1 and Avian-Origin H7N7 Influenza A Virus Infection , 2012, Journal of Virology.

[97]  Yu Li,et al.  Differential microRNA expression and virulence of avian, 1918 reassortant, and reconstructed 1918 influenza A viruses. , 2011, Virology.

[98]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[99]  Adam Grundhoff,et al.  Virus-encoded microRNAs. , 2011, Virology.

[100]  L. Eisenlohr,et al.  Exosome-Driven Antigen Transfer for MHC Class II Presentation Facilitated by the Receptor Binding Activity of Influenza Hemagglutinin , 2010, The Journal of Immunology.

[101]  Bryan R. Cullen,et al.  Virally Induced Cellular MicroRNA miR-155 Plays a Key Role in B-Cell Immortalization by Epstein-Barr Virus , 2010, Journal of Virology.

[102]  Wenlin Huang,et al.  Cellular MicroRNAs Inhibit Replication of the H1N1 Influenza A Virus in Infected Cells , 2010, Journal of Virology.

[103]  A. García-Sastre,et al.  Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines , 2010, PLoS pathogens.

[104]  Guihai Feng,et al.  Identification of host encoded microRNAs interacting with novel swine-origin influenza A (H1N1) virus and swine influenza virus , 2009, Bioinformation.

[105]  J. Steel,et al.  MicroRNA-mediated species-specific attenuation of influenza A virus , 2009, Nature Biotechnology.

[106]  Genevieve DeMaria,et al.  Characterization of exosome‐like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[107]  W. Ritchie,et al.  Predicting microRNA targets and functions: traps for the unwary , 2009, Nature Methods.

[108]  John J. Rossi,et al.  The promises and pitfalls of RNA-interference-based therapeutics , 2009, Nature.

[109]  Alberto Riva,et al.  Kaposi's Sarcoma-Associated Herpesvirus Encodes an Ortholog of miR-155 , 2007, Journal of Virology.

[110]  George G. Brownlee,et al.  In Vitro Assembly of PB2 with a PB1-PA Dimer Supports a New Model of Assembly of Influenza A Virus Polymerase Subunits into a Functional Trimeric Complex , 2005, Journal of Virology.

[111]  L. Pinto,et al.  Demonstrating the intrinsic ion channel activity of virally encoded proteins , 2003, FEBS letters.

[112]  P. Chan,et al.  Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[113]  A. Avan,et al.  Cytokines and MicroRNA in Coronary Artery Disease. , 2017, Advances in clinical chemistry.

[114]  Duo Zhang,et al.  Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo. , 2017, American journal of physiology. Lung cellular and molecular physiology.

[115]  Y. Hu,et al.  MicroRNA-33a disturbs influenza A virus replication by targeting ARCN1 and inhibiting viral ribonucleoprotein activity. , 2016, The Journal of general virology.

[116]  K. Neuzil,et al.  Influenza Vaccines and Vaccination Strategies , 2016 .

[117]  J. Pasick,et al.  Human microRNA-24 modulates highly pathogenic avian-origin H5N1 influenza A virus infection in A549 cells by targeting secretory pathway furin. , 2015, The Journal of general virology.

[118]  C. Feng,et al.  The impact of temperature and humidity measures on influenza A (H7N9) outbreaks-evidence from China. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.